Mark Whitaker spoke with Law360 about the potential shifts in patent policy depending on the outcome of the presidential election. He highlighted the contrasting approaches of the candidates. The article reflects the broader debate on how patent policies might evolve to address issues of access and cost, particularly in the pharmaceutical sector.
Read the full article.
